Bronchial Colonization With Fungi and Late Respiratory Acquired Pneumonia
NCT ID: NCT01770015
Last Updated: 2022-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
213 participants
INTERVENTIONAL
2011-11-30
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can we Better Understand the Development of VAP and Eventually Predict and Prevent it?
NCT01875692
Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive Care
NCT02127528
Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients
NCT04344509
Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens
NCT06554327
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
NCT03752476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ventilated patient
all patients underwent the same diagnostic test . cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization.
HLA DR antigen, cytokines (IL 6 and 10), B-glucan. fungi and bacteria endotracheal aspiration
biological sampling
cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization
sampling blood
HLA DR antigen, cytokines (IL 6 and 10), B-glucan
endotracheal aspiration
fungi and bacteria endotracheal aspiration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biological sampling
cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization
sampling blood
HLA DR antigen, cytokines (IL 6 and 10), B-glucan
endotracheal aspiration
fungi and bacteria endotracheal aspiration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AdministrateurDRC
Pr JF TIMSIT
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
TIMSIT Jean-François, PU/PH
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Grenoble
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital University Clermont Ferrand Gabriel Montpied
Clermont-Ferrand, , France
University Hospital of Grenoble
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Timsit JF, Schwebel C, Styfalova L, Cornet M, Poirier P, Forrestier C, Ruckly S, Jacob MC, Souweine B. Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study. Intensive Care Med. 2019 Jun;45(6):834-843. doi: 10.1007/s00134-019-05622-0. Epub 2019 Apr 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A00767-34
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.